Anocca AB
556946-2384ActiveEngineering precision T-cell immunotherapies for hard-to-treat cancers.
Yleiskatsaus
- 100–199
- Työntekijät
- 750–999t SEK
- Liikevaihto
- 2013
- Perustettu
Avainpäättäjät
Jacob Michlewicz
Chief Finance Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
+37 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Anocca AB is a fully integrated, clinical-stage biopharmaceutical company based in Sweden. The organization specializes in creating libraries of T-cell receptor-engineered T cell (TCR-T) therapies. Their core mission is to redefine the treatment landscape for solid tumors, as well as infectious and...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556946238401
Päättäjät
41 yhteystietoa FunnelfeedrissäJacob Michlewicz
Chief Finance Officer
Niclas Sandberg
Head of Quality Control
Mattias Persson
Head of Engineering
Mikael Blomqvist
Board Member
Niklas Sjökvist
Head of Production
Martin Welschof
Board Member
Fredrik Hansson
Board Member
Sophie Blomqvist
Board Member
Mark Farmery
Chief Development Officer
Christiane Hanke-Harloff
Board Member
Amu Wang
Director of Clinical Operations
Rehab Alnabhan
Clinical Science Lead
Hans Stråberg
Chairman of the Board
Ragnar Lindqvist
Board Member
Arjudeb Mukherjee
VP Strategy & Corporate Development
Luke Pase
Chief Technology Officer
Ryan Hill
Chief Information Officer
Zach Chia
VP Strategy & Business Development
Sheila Forsman
Director of Clinical Development
Jan Lundberg
Board Member
Malin Löfdahl
Director of GMP Operations
Viktor Arnkil
Chief Operating Officer
Zahid Bashir
Chief Medical Officer
Reagan Jarvis
Chief Executive Officer, Scientific founder
Hugh Salter
Chief Scientific Officer
Richard Samuelson
Lead Software Engineer
Suzana Kovac
Patent Portfolio Manager
Mikael Pedin
HR Manager
Dennis Ahlstedt
IT Manager
Athina Totomi
Platform Project Manager
Muut yhteyshenkilöt
Sergey Zelenin
Principal Scientist
Shenqiu Wang
Senior Scientist
Hannes Uchtenhagen
Principal Scientist
Daniela Casarrubea
Principal Scientist
+7 lisää yhteystietoja Funnelfeedrissä
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäCuraCell TX AB
5 työntekijätEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Alvotech Sweden AB
20–49 työntekijätDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Lokon Pharma AB
10–19 työntekijätDeveloping novel gene engineering vectors for cancer immunotherapy.
Asgard Therapeutics AB
10–19 työntekijätPioneering in vivo cell reprogramming for next-generation cancer immunotherapy.
Valo Therapeutics Oy
Developing novel peptide-coated oncolytic virus immunotherapies for cancer.
Selaa lisää
Kysymyksiä yrityksestä Anocca AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo